Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
透過分析師洞察艾伯維公司內部結構
Analysts' ratings for AbbVie (NYSE:ABBV) over the last quarter vary from bullish to bearish, as provided by 10 analysts.
10位分析師提供的分析師對艾伯維（紐約證券交易所代碼：ABBV）在上個季度的評級從看漲到看跌不等。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要概述了他們最近的評級，重點介紹了過去30天中情緒的變化，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $194.2, with a high estimate of $214.00 and a low estimate of $180.00. Marking an increase of 1.15%, the current average surpasses the previous average price target of $192.00.
分析師對12個月目標股價的評估提供了更多見解，顯示平均目標價爲194.2美元，最高估計爲214.00美元，最低估計爲180.00美元。當前的平均價格上漲了1.15％，超過了之前的平均目標股價192.00美元。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析師評級：深度分析
The standing of AbbVie among financial experts is revealed through...
通過對近期分析師行爲...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。